The usage of additional radiotherapy for resected stage IIIA N2 non-small-cell lung cancer in the setting of standard adjuvant chemotherapy remains controversial. P=0.047). In summary, compared with postoperative chemotherapy, POCRT was beneficial to OS but not DFS in patients with stage IIIA N2 non-small-cell lung cancer. Keywords: NSCLC, N2-stage, therapy, surgery Introduction Despite treatment advances,… Continue reading The usage of additional radiotherapy for resected stage IIIA N2 non-small-cell